Skip to main content
Loading

AI-driven Tier 0: Revolutionizing small molecule drug discovery

11 Feb 2027
Lead Generation & Optimization
  • Explore broadly, test selectively. Use computational screening and molecular design to narrow a large chemical space into a focused set of compounds for experimental evaluation.

  • Bring liabilities forward. Assess predicted activity, selectivity, and ADMET properties early to guide chemistry before committing to extensive synthesis.

  • Connect prediction with experiment. Feed laboratory results back into the models to sharpen compound selection, guide optimization, and support earlier program decisions.

Industry Expert
Sanjeev Thoran, Chief Scientific Officer - LatentSpace Therapeutics